TR1 cells
T-cells
Breg cells
B-regulatory cells
autoreactive B-cells
TR1-Breg regulatory pathway
human TR1 CD4
B-regulatory networks
TR1-driven Breg conversion
peripheral blood mononuclear cells
Breg formation
PLNs of pMHC
differentiation of B
autoantigen-experienced T-regulatory
TR1-derived cytokines
human T1D-relevant pMHC class
T-cell formation
NPs
systemic immunity
humanized NSG mice
novel therapeutic approach
new therapeutic platform
career development
recent onset T1D patients
relevant peptide
manufacturing industry
manufacturing bottleneck
new insights
multidisciplinary approach
design of strategies
future clinical development
complexity of autoimmune responses
diabetogenic autoimmune response
NP therapy functions
autoantigen-loaded antigen
critical roles
scalable magnetic separation device
area of huge potential growth
complexes
cognate interaction
diabetic animals
academic research
barrier
diabetes
nanotechnology
biology
epitope-specific manner
translational significance
mechanisms of action
following hypotheses
pancreatic lymph nodes
immune system of autoreactivity
knowledge
normoglycemia
type
recruitment
nanoparticles
compounds
enterprise SEPMAG
autoantigenic specificities
NANOBreg
Santamaria
addition